摘要
目的观察鼓室内注射地塞米松和鼓室正压治疗梅尼埃病的疗效。方法13例难治性梅尼埃病患者鼓室内注射地塞米松,首次剂量5mg,第2天再注射5mg,第2～4周每周注射5mg,同时配合鼓室正压治疗,检测眩晕、听力及耳鸣变化。结果13例随访2～5年,眩晕完全控制9例,明显减轻3例,眩晕6个月后复发,再治疗1个疗程后控制1例。耳鸣消失5例,减轻3例,无效5例,听力提高10～30dB9例,不变4例。结论鼓室内注射地塞米松配合间歇性鼓室正压治疗难治性梅尼埃病能有效地控制眩晕,其操作简单,费用低,患者易于接受。
Objective：To investigate the efficacy of intratyonpanic dexamethasone injections （IDI） and intermittent pressure （IP） for 13 patients with intractable Meniere＇s disease （MD）. Method：Dexamethasone （5 g/L） was injected into the middle ear. The injection was repeated the next day and weekly for 3 weeks. Together with tympanic intermittent pressure （IP）. Result： The 13 patients was followed up for 2-5 years. Complete relief vertigo was maintained in 9 cases,improved in 3 cases. The injection was repeated in 1 patient with recurreut vertigo and total control of vertigo was obtained. Tinuitus disappeared in 5 cases, reduced in 3 case, unchanged in 5 cases. Hearing was improved in 9 cases, unchanged in 4 cases. Conclusion： IDI and IP are effective for intractable MD. The benefits of IDI and IP are easy application for doctors and reasonable cost which can be accepted by patients easily.
出处
《临床耳鼻咽喉科杂志》
CSCD
北大核心
2005年第16期748-749,共2页
Journal of Clinical Otorhinolaryngology
关键词
梅尼埃病
地塞米松
注射
鼓室内
Meniere＇s disease
Dexamethasonel Injections, intratympanic
